Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...
An oncology nurse discusses 4 common barriers certain patient populations face when it comes to oncology clinical trials, and ...
The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of ...
Surveyed individuals who identified as a racial or ethnic minority reported difficulties discussing cancer diagnosis and treatment. Typical stories shared about “going flat” after a mastectomy may not ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback